• Services
    • Equity Reports (Analyst-Ready)
    • Visibility Upgrades (Quartely + As needed)
    • Investor Mapping
  • Press
  • Ask AI
  • Contact
  • English
    • Deutsch (German)
    • 日本語 (Japanese)
    • Services
      • Equity Reports (Analyst-Ready)
      • Visibility Upgrades (Quartely + As needed)
      • Investor Mapping
    • Press
    • Ask AI
    • Contact
    • English
      • Deutsch (German)
      • 日本語 (Japanese)
  • info@vasro.de
  • +49 (0)69 90 28 39 81
  • Call us Mon - Fri: 8:30 AM - 6:00 PM
VASRO GmbH
VASRO GmbH
  • Services
    • Equity Reports (Analyst-Ready)
    • Visibility Upgrades (Quartely + As needed)
    • Investor Mapping
  • Press
  • Ask AI
  • Contact
  • English
    • Deutsch (German)
    • 日本語 (Japanese)

Press

VASRO GmbH > Press
VASRO GmbH

Key Energy Equity Trends Shaping 2025

  • August 5, 2025
  • Energy
Equity trends in 2025 highlight clean energy growth, improved access, and affordability, shaping a fairer energy future for all communities and investors.
Continue Reading
VASRO GmbH

Pharmaceutical Equity Trends: 2025 Forecast for Drug Pricing and Reimbursement

  • August 4, 2025
  • Pharma & Biotech
Pharmaceutical equity trends in 2025 shape drug pricing, reimbursement, and access as new policies, AI, and market forces drive affordability and innovation.
Continue Reading
VASRO GmbH

Top 5 AI Stocks: Equity Report Analysis of Leading Tech Innovators

  • August 1, 2025
  • Tech
Top 5 KI-Aktien im Vergleich: Chancen, Risiken und Analysen führender Tech-Innovatoren für Anleger. Jetzt die wichtigsten Unterschiede und Trends erfahren.
Continue Reading
VASRO GmbH

Biotechnology stock risk indicators to mitigate volatility with market intelligence

  • July 30, 2025
  • Pharma & Biotech
Biotechnologie-Aktienrisikoindikatoren und Marktintelligenz ermöglichen es, Volatilität gezielt zu steuern und Risiken bei Biotech-Investments zu minimieren.
Continue Reading
VASRO GmbH

How to Conduct a Deep Dive Equity Report

  • July 28, 2025
  • Unkategorisiert
Conduct a Deep Dive Equity Report with step-by-step guidance on data collection, financial analysis, valuation, and risk assessment for investment decisions.
Continue Reading
VASRO GmbH

Emerging Market Equities opportunities beyond Western tech

  • July 25, 2025
  • Commodity, Tech
Emerging Market Equities offer growth and diversification beyond Western tech, with opportunities in fintech, consumer, and industrial sectors worldwide.
Continue Reading
VASRO GmbH

Future of Pharma Equity: AI, Precision Medicine, and Market Intelligence Trends

  • July 24, 2025
  • Pharma & Biotech
Pharma equity evolves as AI, precision medicine, and market intelligence drive innovation, improve patient outcomes, and address health equity challenges.
Continue Reading
VASRO GmbH

Equity Report takeaways comparing Pharma vs. Tech performance

  • July 23, 2025
  • Pharma & Biotech, Tech
Equity Report reveals tech firms outperform pharma in returns and growth, driven by rapid innovation, while pharma faces regulatory and operational hurdles.
Continue Reading
VASRO GmbH

Renewable Energy Equity Scores and How to Use ESG Data

  • July 22, 2025
  • Energy
Renewable energy equity scores use ESG data to assess company sustainability, manage risk, and guide responsible investment in the renewable energy sector.
Continue Reading
VASRO GmbH

AI-Enabled Market Intelligence: Real-Time Equity Insights for Energy sectors

  • July 21, 2025
  • Energy
AI-enabled market intelligence delivers real-time equity insights, empowering energy sector leaders with data-driven decisions and improved operational efficiency.
Continue Reading

Posts pagination

Previous 1 … 14 15 16 … 37 Next

Search

Categories

  • Energy
  • Equity Analysis reports
  • Equity Research Coverage
  • Market Intelligence
  • Pharma & Biotech
  • Tech
  • Unkategorisiert

Recent Posts

Sirnaomics Ltd.: The RNAimmune Money Is In, and the FDA Has Answered in Writing on STP705 October 12, 2026
Ainos, Inc.: A Partner Pays for VELDONA, and Ainos Keeps the Platform September 29, 2026
Ainos Inc: A Front-End Customer Starts Ordering, and the Dataset Passes a Billion September 16, 2026
Ainos, Inc.: Three Patents Approved in Japan, and a Dataset Gathering Pace September 11, 2026
Baladna: The Capital Is Raised, Algeria Is Building – VASRO Reiterates BUY at QAR 2.33 September 7, 2026
VASRO GmbH
VASRO GmbH specializes in equity analysis, market intelligence, and investment strategy for the pharmaceutical, biotechnology, and IT sectors. We deliver tailored insights to drive informed investment decisions and achieve exceptional results.

Discover More

Contact Info

  • Am Hauptbahnhof 16, 60329 Frankfurt am Main, Germany
  • +49 (0)69 90 28 39 81
  • info@vasro.de
  • 8:30 AM - 6:00 PM

Navigation

  • Imprint
  • Privacy Policy
  • Change privacy settings
  • Application
  • About
  • FAQ

©copyright 2025 VASRO GmbH.